Read more
Today, the integration of life insurance medicine into the framework of general medicine goes without saying. On the one hand, the diagnostic therapeutic knowledge of clinical medical science forms the tools of the insurance medical adviser for the evaluation of life insurance applications. On the other hand, life insurance medicine has been able to pro vide valuable statistical data for long-term prognosis which have become an essential part of the daily medical practice and prognostic appraisal. This mutual engagement and en richment has again distinctly manifested itself in the scientific program of the 13th Con gress of Life Assurance Medicine held in Madrid. Among the broad and varied data available, the insurance problem of cancer and ma lignant diseases of the haematopoietic system were extensively dealt with for the first time. Diagnostic therapeutic progress increasingly allows valuable insurance cover to be granted to formerly uninsurable risks, a group which is particularly in need of, and re quires, life insurance cover. The number of risks which are uninsurable becomes smaller and smaller.
List of contents
I Sesión.- Angeborene Herzfehler..- Muscoviscidose (Cystische Fibrose) und Alpha-1-Antitrypsinmangel..- Aberrations chromosomiques..- Anomalías congénitas del tracto urogenital, especialmente de los riñones..- II Sesión.- Hemorrhagic Diseases..- Life Expectation and Court Awards in Paraplegia and Tetraplegia..- Life Insurance Risks and Diabetes..- Nebenerkrankungen des Diabetes und ihre Prognose..- III Sesión.- The Prognosis of Myeloma and Macroglobulinemia..- Prognosis of Malignant Lymphomas..- The Present State of "Curability" of Leukaemias Including Polycythaemia Vera..- Late Effects of Chemotherapy..- IV Sesión.- Cancer Mortality - A Recent Study..- Cancer Survival and Mortality Trends 1950 - 59 to 1960 - 73..- Variations in Cancer Mortality..- V Sesión.- Diagnosis and Prognosis of Cardiomyopathies..- Valve Replacement..- Métodos no invasivos en el diagnóstico de las cardiopatías: Nuevas técnicas..- Pathophysiologie, Klinik und prognostische Bedeutung der Hyperlipoproteinämien..- VI Sesión.- Enfoque moderno de las pruebas de esfuerzo en la selección de riesgos..- Neurosen und Versicherung..- Consideraciones sobre los resultados de 1.500 reconocimientos médicos..- Laboruntersuchungen in der Lebensversicherungsmedizin..- Pronóstico y evolución de la Colitis ulcerosa..- Author Index.
Summary
Today, the integration of life insurance medicine into the framework of general medicine goes without saying. On the one hand, the diagnostic therapeutic knowledge of clinical medical science forms the tools of the insurance medical adviser for the evaluation of life insurance applications. On the other hand, life insurance medicine has been able to pro vide valuable statistical data for long-term prognosis which have become an essential part of the daily medical practice and prognostic appraisal. This mutual engagement and en richment has again distinctly manifested itself in the scientific program of the 13th Con gress of Life Assurance Medicine held in Madrid. Among the broad and varied data available, the insurance problem of cancer and ma lignant diseases of the haematopoietic system were extensively dealt with for the first time. Diagnostic therapeutic progress increasingly allows valuable insurance cover to be granted to formerly uninsurable risks, a group which is particularly in need of, and re quires, life insurance cover. The number of risks which are uninsurable becomes smaller and smaller.
